Ross operation with a tissue-engineered heart valve.

نویسندگان

  • Pascal M Dohmen
  • Alexander Lembcke
  • Holger Hotz
  • Dietmar Kivelitz
  • Wolfgang F Konertz
چکیده

BACKGROUND The Ross procedure has gained increasing acceptance due to excellent hemodynamic results by replacing the diseased aortic valve with the viable autologous pulmonary valve. Consequently, the right ventricular outflow tract (RVOT) has to be reconstructed. In this report a viable heart valve was created from decellularized cryopreserved pulmonary allograft that was seeded with viable autologous vascular endothelial cells (AVEC). METHODS A 43-year-old patient suffering from aortic valve stenosis underwent a Ross operation on May 20, 2000, using a tissue engineered (TE) pulmonary allograft to reconstruct the RVOT. Four weeks before the operation a piece of forearm vein was harvested to separate, culture, and characterize AVEC. Follow-up was completed at discharge, 3, 6, and 12 months postoperatively by clinical evaluation, transthoracic echocardiography (TTE), and magnetic resonance imaging (MRI). Additionally, at 1-year follow-up a multislice computed tomographic scan was performed. RESULTS After four weeks of culturing 8.34 x 10(6) AVEC were available to seed a 27-mm decellularized pulmonary allograft. Trypan blue staining confirmed 96.0% viability. Reendothelialization rate after seeding was 9.0 x 10(5) cells/cm2. TTE and MRI revealed excellent hemodynamic function of the TE heart valve and the neoaortic valve as well. Multislice computed tomography revealed no evidence of valvular calcification. CONCLUSIONS After 1 year of follow-up the patient is in excellent condition without limitation and exhibits normal aortic and pulmonary valve function.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Doppler echocardiographic findings in tissue engineered aortic valve in a sheep model

Background: Heart valve diseases are considered a common disease in human and animals, and valve replacement is an option for treatment of valvular diseases. Objectives: In this study efficacy of a tissue engineered valve in thoracic aorta was evaluated with transthoracic echocardiography. Methods: This study was undertaken on 6 male sheep. Echocardiography was performed on all sheep 24 hours b...

متن کامل

Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation.

BACKGROUND AND AIM OF THE STUDY Aortic valve disease can be treated successfully by means of the Ross operation. Alternatives to pulmonary valve replacement with homografts are needed. The study aim was to demonstrate the performance of a decellularized porcine xenograft valve (Matrix P) in adult patients after the Ross operation. METHODS Between July 2002 and May 2004, a total of 50 Ross ope...

متن کامل

Ross operation and right ventricular outflow tract reconstruction with stentless xenografts.

Traditionally a homograft valve is used as a pulmonary replacement device for the Ross operation. Right ventricular outflow tract reconstruction during aortic valve replacement with an autograft was performed with stentless xenograft valves in nine patients. Hemodynamic performance is satisfying, but, long term evaluation is needed.

متن کامل

Ross operation for bicuspid aortic valve: the myth, the reality.

I read with great interest the article by Hraska et al. [1], in the May issue of EJCTS, summarizing their 7 years experience with the Ross and Ross–Konno operation in children and adolescents in two centers. Like most other series, their mid-term experience validates the safety and efficacy of Ross operation in treating aortic valve disease in this important subset of patients where growth, act...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • The Annals of thoracic surgery

دوره 74 5  شماره 

صفحات  -

تاریخ انتشار 2002